Trading Signals: FOLD Stock Price Prediction and Forecast (Thu. May. 31, 2007 - Fri. Dec. 22, 2023)(Amicus Therapeutics Inc)
| FOLD latest price $10.5200 (6.59%) ($10.0100 - $10.6300) on Wed. Feb. 5, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.26% (three month average) | RSI | 49 | Latest Price | $10.5200(6.59%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | FOLD advances 2.8% a day on average for past five trading days. | Weekly Trend | FOLD declines -3.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support FOLD advance at 0% a week (0% probability) IBB(60%) IWO(56%) XBI(55%) IWM(53%) IWC(51%) | Factors Impacting FOLD price | FOLD will decline at least -1.63% in a week (0% probabilities). VIXM(-33%) VXX(-19%) TLT(-14%) TIP(-1%) SHY(-1%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.63% (StdDev 3.26%) | Hourly BBV | 0 () | Intraday Trend | 5.1% | | | |
|
5 Day Moving Average | $9.45(11.32%) | 10 Day Moving Average | $9.27(13.48%) | 20 Day Moving Average | $9.53(10.39%) | To recent high | -2.1% | To recent low | 20.9% | Market Cap | $2.717b | | | | Amicus Therapeutics, Inc. is a biotechnology company focused on discovering, developing, and delivering medicines for people living with rare metabolic diseases. The company is committed to advancing and expanding a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. Amicus Therapeutics has a portfolio of product opportunities including the first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants; a novel, clinical-stage, treatment paradigm for Pompe disease; and a rare disease gene therapy portfolio. The company was founded on February 4, 2002 and is headquartered in Cranbury, NJ. |